MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study (Q27852083)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q32649390)
(Q32649861)
(Q32650033)
(Q89457677)
(Q89370036)
(Q89612541)
(P304) 249-56
(P433) 3
(P478) 14
(P577) +2013-03-00T00:00:00Z
(P1433) (Q13747613)
(P1476) "MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study" (language: en)
(P2093) Sanjiv S Agarwala
Carla Ml van Herpen
Paola Queirolo
J Thaddeus Beck
Annie St-Pierre
Faiz Niazi
Simon Wandel
Malte Peters
Angela Zubel
(P2860) (Q70313347)
(Q29619885)
(Q28378420)
(Q34629364)
(Q27861062)
(Q35679353)
(Q37999445)
(Q24631953)
(Q53640355)
(Q27851695)
(Q95821063)
(Q29614756)
(Q29620663)
(Q24632064)
(Q37982476)
(Q27777362)
(Q39802879)
(Q27851801)
(Q24594790)
(Q27851617)
(Q48499411)
(Q29614965)
(Q34569987)
(Q54587263)
(Q29614281)
(Q34633455)
(Q27851856)
(Q35621653)
(Q36929804)
(Q42466391)
other details
description scientific article

External Links